is the fda banning semaglutide U.S. finds no evidence yet linking weight-loss drugs to suicidal thoughts FDA Drug Recalls and Warnings:
Description
adding B12) and a few more hoops to jump through such as questionnaires as to why your patient needs the B12 infused version

Our single-center study was retrospective in nature and thus depended on accurate documentation in the electronic medical record

Frontiers in Pharmacology

Diabetes 2002

Negativity bias dominates social media

Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice
